drugset / Trial / NCT01314209
Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine dexmedetomidine pharmacokinetics during continuous renal replacement therapy on critically ill patients.
Timeline
- Start
- 2011-03
- Primary completion
- 2014-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | Intravenous |